Fxtradingremedy is a platform offering trading in forex, cryptocurrencies, and binary options, with an official website domain of fxtradingremedy.com. A Whois search shows that the domain was registered on June 17, 2024. However, in the process of verifying the authenticity of the platform's official information, it was found that the platform does not exist as a real company entity.
Company Background
The platform claims to be a subsidiary of Fxtradingremedy Plc and states its parent company has a history of over a century, being one of the largest in the world. The official website's public information states that the company was founded in 2012, aiming to help more people enter the investment market and achieve financial freedom. The history of the company's business development is as follows:
- 2013: The company started sponsoring innovative projects and expanded operations from single individuals to multiple private equity funds.
- 2014: The company adjusted its fund management model and launched private closed funds to ensure professional and private fund management.
- 2015: The company underwent infrastructure reforms, enhancing liquidity, clearing engines, and institutional frameworks to serve the retail market.
- In recent years, the company has used social media (such as Facebook) to expand its business, attracting more international investors.
Although the official platform claims the company has a century-long history and is active on social media, no information about its parent company can be found through public channels, nor can any official account or authentic information about the platform be found on major platforms such as LinkedIn, Facebook, Instagram, or Twitter. This clearly contradicts the platform's description, indicating a risk of misinformation.
Core Business
Fxtradingremedy claims to offer fund management services and is dedicated to managing traders' funds, involving both short-term and long-term investment projects, with special emphasis on fund security and high returns. However, the platform does not disclose specific fund operation models and investment strategies, questioning its business transparency.
More importantly, the platform claims to have joined the Investor Compensation Fund (ICF) in the U.S. and has contracting qualifications in Europe, but in reality, there is no "Investor Compensation Fund" institution in the U.S.; the main institution protecting investors' assets is the Securities Investor Protection Corporation (SIPC). In Europe, an ICF does exist, but this does not mean that all European countries have similar protections.
Therefore, the platform's claim of an "Investor Compensation Fund (ICF)" has clearly false components.
Regulatory Information
Fxtradingremedy claims to be certified by the U.S. government, fully registered and regulated in the U.S., and has received authorization from the UK Financial Conduct Authority (FCA).
However, upon verification, records of regulatory authorization for this platform cannot be found on the official websites of the UK Financial Conduct Authority (FCA) and the U.S. Securities and Exchange Commission (SEC), indicating that the platform is not supervised by relevant financial regulatory agencies, and users should remain vigilant about the platform's legality.
Investment Plans
Fxtradingremedy offers five investment plans, namely the Starter Plan, Master Plus Plan, Premium Plan, Ultimate Plan, and Corporate Plan, each promising high returns. These rates are abnormally high and fixed, revealing typical Ponzi scheme characteristics. The specific plans are as follows:
- Starter Plan ($500+): Expected return rate of 20%, commission 10%.
- Master Plus Plan ($1,000+): Expected return rate of 40%-50%, commission 10%.
- Premium Plan ($5,000+): Expected return rate of 50%-60%, commission 10%.
- Ultimate Plan ($10,000+): Expected return rate of 60%-70%, commission 10%.
- Corporate Plan ($100,000+): Expected return rate of 70%-80%, commission 10%.
The excessively high promised return rates and the undisclosed fund operation model suggest that the funds may stem from subsequent investors' capital rather than actual profits. High returns, refund guarantees, and opaque fund sources are typical characteristics of Ponzi schemes.
Deposits/Withdrawals
The platform claims to support a variety of deposit methods, including bank wire transfer, PayPal, Neteller, Skrill, MoneyGram, MasterCard, Bitcoin, Western Union, and Perfectmoney, etc.
Withdrawal methods require investors to submit a request through their account or contact an account manager and provide relevant documents for review. After the finance department processes the withdrawal request, payments are made monthly with a minimum withdrawal requirement of $70.
However, considering the platform's questionable legitimacy, the smoothness and transparency of deposits and withdrawals may entail significant risks.
Company Address and Staff
The Fxtradingremedy official website claims its operational address is 1000 Main St 12th Floor, Houston, TX 77002, USA, but investigation reveals that this address is located in a shared office building with multiple companies leasing office space, and no registration information related to this platform is found.
Furthermore, the address is consistent with multiple scam websites, further indicating that the platform may be linked to other fraudulent schemes.
Additionally, the official site does not provide company member information, nor can any employee information about the company be found publicly online.
Website Traffic and Templates
According to Semrush data, fxtradingremedy.com has an average monthly traffic of fewer than 100 visits, suggesting almost no users are using the platform.
More seriously, the platform's official site shares the same website design template with multiple scam sites, such as Digital Coin Forge, Invest Capital Exchange, and autofxearners, indicating these platforms may be mass-produced by the same producer team, further suggesting their fraudulent nature.
User Feedback and Brand Exposure
No user reviews or news reports regarding Fxtradingremedy can be found online, indicating the platform's public and media exposure is extremely low, raising further doubts about its legitimacy.
Contact Information
The contact information provided on the official platform includes a phone number: +44 7852 961891 and an email: [email protected].
Risk Report
Based on the above information, the Fxtradingremedy platform presents the following major risks:
- Lack of a Real Company Entity: Fails to provide effective company registration information and address, and lacks public records of the parent and subsidiary companies.
- False Company Background and Regulatory Information: Regulatory information provided by the platform cannot be verified, and the investor compensation fund statement is false.
- Ponzi Scheme Characteristics: Investment plans promise high returns, and fund sources are opaque, showing clear signs of a Ponzi scheme.
- Fund Security Issues: Although the platform supports multiple payment methods, its lack of transparency in fund operations presents significant risks in the withdrawal process.
- Low Website Traffic and Template Similarity: Extremely low website traffic and use of similar templates with multiple scam platforms increase the likelihood of fraud.
- Lack of Brand Exposure: The inability to find any effective user reviews or news reports further questions its trustworthiness.
Therefore, investors should remain highly cautious of this platform and avoid involvement.
